We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Parental Involvement and Children's Extra-Familial Contexts

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00538252
First Posted: October 2, 2007
Last Update Posted: December 11, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Daniel Shaw, University of Pittsburgh
  Purpose
Parental involvement has been shown to be a robust predictor of child conduct problems (CP) and drug use risk in childhood and adolescence, but relatively little attention has been paid to the role of parental involvement in relation to child problem behavior during the transition to school-age, when children are spending more time in school, after-care settings, and in the neighborhood. Concomitantly, as children transition from preschool to school-age, there is evidence to suggest that the quality and organization of schools, after-school care, and neighborhoods play an increasingly important role in the emergence of children's CP and drug use risk. Specifically, we will address: 1) the extent to which the quality of school environments, after-school care, and neighborhoods are associated with the emergence of CP during the early school-age period; 2) how parental involvement in the toddler and preschool period may be associated with parental involvement and monitoring in extra-familial contexts in the early school-age years; 3) how parental involvement in schools, after-care, and the neighborhood, may moderate relationships between extra-familial factors and children's CP; and 4) whether a parenting intervention can increase parental involvement in school, after-care, and neighborhood contexts and decrease risk of children's subsequent CP. These issues will be tested with an existing sample of 731 ethnically-diverse children from urban, suburban, and rural sites. As all families in the study were recruited based on the presence of sociodemographic, family, and child risk factors, the cohort of children are at high risk for displaying a persistent trajectory of clinically-meaningful CP and drug use risk. Thus, the study has the potential to fill a much-needed void on associations between extra-familial contexts and risk for early-starting CP and later problem behavior during the early school-age years. Equally critical, the study can provide data on the potential moderating influence of involved parenting, its malleability for families facing multiple adversities, and whether family-based interventions can make a difference for children facing multiple adversities.

Condition
Prevention of Drug Abuse Risk

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Prospective
Official Title: Parental Involvement, Extra-Familial Contexts and Prevention of Drug Use Risk

Further study details as provided by Daniel Shaw, University of Pittsburgh:

Primary Outcome Measures:
  • Achenbach Teacher Report Form [ Time Frame: collected annually when children are ages 7 to 9 years old ]
    Teachers reports on over 100 items covering children's externalizing and internalizing problem behavior


Secondary Outcome Measures:
  • Parental Monitoring Inventory [ Time Frame: Collected annually when children are ages 7 to 9 ]
    Both children and parents report on the amount and quality of monitoring parents provide regarding their children's after-school activities


Enrollment: 731
Study Start Date: May 2007
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   2 Years to 3 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
731 toddlers and their families followed from age 2 to 9 recruited on the basis of low socioeconomic status, and the presence of family (e.g., parental depression, drug use) and child (disruptive behavior) risk.
Criteria

Inclusion Criteria:

  • Previously enrolled sample of 731 children recruited on the basis of prior screening for socioeconomic, family, and child risk factors at age 2

Exclusion Criteria:

  • All children and families needed to have a child 2-3 years of age with multiple socioeconomic, family, and child risk factors.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00538252


Locations
United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15260
Sponsors and Collaborators
University of Pittsburgh
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Daniel S. Shaw, Ph.D. University of Pittsburgh
  More Information

Responsible Party: Daniel Shaw, Professor and Chair, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00538252     History of Changes
Other Study ID Numbers: involvementincontext
R01DA023245 ( U.S. NIH Grant/Contract )
DA023245
First Submitted: October 1, 2007
First Posted: October 2, 2007
Last Update Posted: December 11, 2013
Last Verified: December 2013

Keywords provided by Daniel Shaw, University of Pittsburgh:
drug use, antisocial behavior, early intervention, prevention

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders